Paget disease of bone

30,725views

Paget disease of bone

(S1) PBL Exam 1

(S1) PBL Exam 1

Osteoporosis
Paget disease of bone
Osteomalacia and rickets
Inflammation
Phosphate, calcium and magnesium homeostasis
Bone remodeling and repair
Vitamin D
Bone disorders: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Parathyroid hormone
Calcitonin
Hyperparathyroidism
Cytokines
Leukocyte adhesion deficiency
Complement deficiency
Pediatric bone and joint infections: Clinical
Osteomyelitis
Septic arthritis
Bacterial structure and functions
Topoisomerase inhibitors
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Protein synthesis inhibitors: Tetracyclines
Protein synthesis inhibitors: Aminoglycosides
Miscellaneous protein synthesis inhibitors
Skin and soft tissue infections: Clinical
Cell wall synthesis inhibitors: Penicillins
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
Cellulitis
Erysipelas
Impetigo
Necrotizing fasciitis
Folliculitis
Varicella zoster virus
Sporothrix schenckii
Obstructive lung diseases: Pathology review
Asthma
Bronchiectasis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Cystic fibrosis
Chronic obstructive pulmonary disease (COPD): Clinical
Emphysema
Alpha 1-antitrypsin deficiency
Acid-base map and compensatory mechanisms
Acid-base disturbances: Pathology review
The role of the kidney in acid-base balance
Tubular reabsorption and secretion of weak acids and bases
Buffering and Henderson-Hasselbalch equation
Respiratory acidosis
Metabolic acidosis
Plasma anion gap
Respiratory alkalosis
Metabolic alkalosis
Mendelian genetics and punnett squares
Complement system
Compliance of lungs and chest wall
Lung volumes and capacities
Ventilation-perfusion ratios and V/Q mismatch
Acute respiratory distress syndrome
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Alveolar surface tension and surfactant
Anatomic and physiologic dead space
Ventilation
Airflow, pressure, and resistance
Pleural effusion
Pneumothorax
Mesothelioma
Anatomy of the pleura
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Anatomy clinical correlates: Pleura and lungs
Regulation of pulmonary blood flow
Gas exchange in the lungs, blood and tissues
Diffusion-limited and perfusion-limited gas exchange
Zones of pulmonary blood flow
Carbon dioxide transport in blood
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Sleep apnea
Pulmonary hypertension
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Pulmonary embolism
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Factor V Leiden
Disseminated intravascular coagulation
Protein C deficiency
Antiphospholipid syndrome
Heparin-induced thrombocytopenia
Antiplatelet medications
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Chronic bronchitis
Iron deficiency anemia
Vitamin B12 deficiency
Autoimmune hemolytic anemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Beta-thalassemia
Alpha-thalassemia
Phenylketonuria (NORD)
Galactosemia

Transcript

Watch video only

Paget disease of bone is a disorder in which there’s a lot of bone remodeling that happens in some regions of the bone.

Typically there’s excessive bone resorption followed by excessive bone growth, and it leads to skeletal deformities and potential fractures.

Normally, bones undergo a continuous process of bone remodeling.

Old brittle bone tissue gets reabsorbed by multinucleated bone cells called osteoclasts, which have 5 to 20 nuclei per cell.

The resorbed bone tissue gets replaced by a new one made by another type of bone cell called an osteoblast.

At the cellular level, the process begins when osteoblasts release receptor activator of nuclear factor κβ ligand, or RANKL for short, which is a substance that binds to RANK receptors on the surface of osteoclast.

When RANKL binds to the RANK receptor, it activates the osteoclasts, and they start secreting lysosomal enzymes like collagenase as well as hydrochloric acid.

Together they digest the collagen protein and dissolve the minerals that make up the bone matrix.

Once there’s been sufficient bone demineralization, the osteoblasts secrete another substance called Osteoprotegerin, or OPG for short, which binds RANKL and prevents it from activating the RANK receptors. This causes the osteoclasts to stop demineralizing the bones.

Once that happens, the osteoblasts start secreting a substance called osteoid seam, which is mainly made up of collagen and acts like a scaffold upon which calcium and phosphate can get deposited. And that’s how new bone begins to get formed again.

The exact cause of Paget disease of bone is unclear, but it can get triggered by infections like the measles virus, and is linked to genetic mutations like the SQSTM1 mutation, which encodes a protein involved in regulating osteoclasts.

When Paget disease of bone occurs, it can affect a single bone or the whole skeletal system.

Most often, it involves the skull, lumbar vertebrae, the pelvis, and the femur.

Now, there are three main phases to the disease.

Phase one is the lytic phase, and that’s where osteoclasts, which have up to 100 nuclei, start to aggressively demineralize the bone up to 20 times more than normal.

Phase two is the mixed phase, and that’s where the lytic phase occurs alongside the blastic phase.

In the blastic phase, there’s a rapid but relatively disorganized proliferation of new bone tissue by an unusually large number of osteoblasts. The result is that collagen fibers are deposited in a haphazard way.

Phase three is the sclerotic phase, and that’s where new bone formation exceeds bone resorption, and the final result is bone that’s structurally disorganized and therefore weaker than normal healthy bone.

Key Takeaways

Paget's disease of bone, also known as osteitis deformans, is a chronic bone disorder that causes the bone to become thick, weak, and deformed. It commonly affects the pelvis, femur, and lower lumbar spine though it can affect any bone in the body.

Paget disease is associated with an increased risk of fractures, arthritis, and bone tumors. Symptoms may include pain in the affected bone or due to arthritis or nerve impingement. Treatment involves medications to slow the progression of the disease, such as bisphosphonates, pain relievers, and surgery to correct deformities or stabilize fractures.

Sources

  1. "Robbins Basic Pathology" Elsevier Canada (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK)" McGraw Hill Professional (2014)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Paget's Disease of Bone" New England Journal of Medicine (2013)
  6. "Epidemiology and pathology of Paget’s disease of bone – a review" Wiener Medizinische Wochenschrift (2016)
  7. "Pathogenesis of Paget Disease of Bone" Calcified Tissue International (2012)